Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 4 7Phase 1 7Phase NA 6Phase 1/2 4Phase 2/3 3Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Myeloid 1Gynecologic 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Hearing Loss, Sensorineural 1Hearing Loss 1Ear Diseases 1Deafness 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Acetylcysteine × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

NCT05123365 2026-03-10

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

University of California, Irvine

Phase 1/2 Recruiting
27 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Sunnybrook Health Sciences Centre

Phase 1/2 Unknown
80 enrolled

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

NCT03492047 2020-02-27

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Ain Shams University

Phase 1/2 Completed
75 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡